Enoxaparin Sodium Injection Market Report 2025 (Global Edition)

Global Enoxaparin Sodium Injection Market Report 2025 Market Size Split by Type (30 mg/0.3mL, 60 mg/0.6mL, 100 mg/1mL, 120 mg/0.8mL, 150 mg/1mL), by Application (Prevents Intravenous Thrombosis, Deep ...

Enoxaparin Sodium Injection Market Report Description

We have various report editions of Enoxaparin Sodium Injection Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Impact of Tariff Trumph on Pharmaceuticals Industry

The reintroduction of tariffs under President Trump’s “Liberation Day Tariffs” in April 2025 has created significant disruption in global pharmaceutical trade. These tariffs, ranging from 10% to 46%, specifically target pharmaceutical products, APIs (active pharmaceutical ingredients), medical packaging, and machinery from key manufacturers in China and India. This has led to increased production costs, supply chain delays, and regulatory challenges for U.S.-based pharmaceutical companies.

The tariffs have particularly impacted generic drug manufacturers, who rely heavily on APIs from China and India. Biopharmaceuticals and vaccines are also feeling the pressure, with tariffs on critical materials like bioproduction media and cold-chain packaging raising costs by up to 25%. Similarly, contract manufacturing organizations (CMOs) are grappling with the need to identify new suppliers and adjust production plans to mitigate rising costs.

Foreign governments, including the European Union, have retaliated with tariffs on U.S. pharmaceutical exports, further complicating global trade. Clinical trials are also impacted, as tariffs on drugs and diagnostic kits delay trial timelines.

Market research is increasingly crucial for navigating these challenges. By providing real-time data on API pricing, supplier reliability, and tariff impact, pharmaceutical firms can make informed decisions on sourcing, compliance, and investment strategies. This data-driven approach helps mitigate risks, optimize supply chains, and identify alternative manufacturing hubs to offset tariff-related disruptions.

Overall, market research is essential for pharmaceutical companies to adapt to the new tariff landscape, enabling them to maintain competitive advantage and navigate global trade dynamics effectively.

Enoxaparin Sodium Injection Market Insights Video

Competitive Landscape of the Enoxaparin Sodium Injection Market

The competitive landscape of the Enoxaparin Sodium Injection market features a number of major players with a keen interest in achieving a considerable share of this market. Major pharmaceutical companies with production and distribution rights for this anticoagulant drug manufacture and distribute their product throughout the market. Competition in this space is generated through constant innovation of new products, price strategies, and expansion of distribution networks with the aim of raising their presence in the market. This market is further driven by the escalating rates of anticoagulation-requiring conditions, such as deep vein thrombosis and pulmonary embolism, in this population. Another aspect that directly affects competition includes regulatory approvals and biosimilars

In August 2023, Venus Remedies, an Indian pharmaceutical company, reached a crucial milestone by receiving marketing permission for its enoxaparin prefilled syringes in the Kingdom of Saudi Arabia. (Source: https://www.times.venusremedies.com/venus-remedies-secures-marketing-approval-for-enoxaparin-in-saudi-arabia/) In July 2023, Rovi launched its Enoxaparin biosimilar in Jordan and Sri Lanka. It will expand internationally in additional markets with high growth potential through license agreements. (Source: https://www.edisongroup.com/research/biosimilar-enoxaparin-launches/19870/)

Top Companies Market Share in Enoxaparin Sodium Injection Industry: (In no particular order of Rank)

• Sanofi
• Techdow (Hepalink)
• Teva
• Nanjing King-friend
• Rovi
• Fresenius Kabi
• Fosun Pharma(Gland Pharma)
• Amphastar
• Sandoz (Novartis)
• Apotex
• Huadong Medicine
• Cipla
• Taj Pharma
• Chengdu Baiyu Pharmaceutical
• Changzhou Qianhong Bio-pharma
• Beijing SL Pharmaceutical
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Enoxaparin Sodium Injection Market

Which Region Dominates the Enoxaparin Sodium Injection Market in 2024?

According to Cognitive Market Research, North America is the biggest market leader in Enoxaparin Sodium Injections due to various prominent factors. First and foremost, due to a high incidence of cardiovascular diseases and thromboembolic disorders, the requirement for effective treatments that could overcome anticoagulation is at an all-time peak in North America.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific is expected to lead during the forecast period with the highest compound annual growth rate CAGR of Enoxaparin Sodium Injection sales. This is attributed to factors such as the rapidly growing prevalence of chronic diseases, improvements in healthcare infrastructure, and a rising awareness of preventive healthcare among populations

The current report Scope analyzes Enoxaparin Sodium Injection Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

North America Enoxaparin Sodium Injection Market Analysis

According to Cognitive Market Research, the global Enoxaparin Sodium Injection market size was estimated at USD 4415.2 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 1766.08 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.7% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Enoxaparin Sodium Injection market with a market size of USD 1393.44 million in 2024 and is projected to grow at a CAGR of 9.5% during the forecast period. The U.S. market's increasing prevalence of chronic conditions
• The Canada Enoxaparin Sodium Injection market had a market share of USD 211.93 million in 2024 and is projected to grow at a CAGR of 10.5% during the forecast period. Canada’s Advanced Healthcare Infrastructure.
• The Mexico Enoxaparin Sodium Injection market is projected to witness growth at a CAGR of 10.2% during the forecast period, with a market size of USD 160.71 million in 2024.

Europe Enoxaparin Sodium Injection Market Analysis

According to Cognitive Market Research, the global Enoxaparin Sodium Injection market size was estimated at USD 4415.2 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 1324.56 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.0% from 2024 to 2031.

• The United Kingdom Enoxaparin Sodium Injection market had a market share of USD 222.53 million in 2024 and is projected to grow at a CAGR of 10.8% during the forecast period. In the UK, Enoxaparin Sodium Injection sales witness an upswing due to the increased awareness among healthcare providers
• The France Enoxaparin Sodium Injection market is projected to witness growth at a CAGR of 9.2% during the forecast period, with a market size of USD 121.86 million in 2024.
• According to Cognitive Market Research, the German Enoxaparin Sodium Injection market size was valued at USD 262.26 million in 2024 and is projected to grow at a CAGR of 10.2% during the forecast period. In Germany, Enoxaparin Sodium Injection surged due to the increasing prevalence of cardiovascular diseases and thromboembolic disorders.
• The Italy Enoxaparin Sodium Injection market is projected to witness growth at a CAGR of 9.4% during the forecast period, with a market size of USD 113.91 million in 2024.
• The Russia Enoxaparin Sodium Injection market is projected to witness growth at a CAGR of 9.0% during the forecast period, with a market size of USD 205.31 million in 2024.
• The Spain Enoxaparin Sodium Injection market is projected to witness growth at a CAGR of 9.1% during the forecast period with a market size of USD 108.61 million in 2024
• The Luxembourg Enoxaparin Sodium Injection market is projected to witness growth at a CAGR of 10.1% during the forecast period, with a market size of USD 41.06 million in 2024.
• The Portugal Enoxaparin Sodium Injection market is projected to witness growth at a CAGR of 9.8% during the forecast period, with a market size of USD 27.82 million in 2024.
• The Greece Enoxaparin Sodium Injection market is projected to witness growth at a CAGR of 10.3% during the forecast period, with a market size of USD 15.89 million in 2024.
• The Rest of Europe's Enoxaparin Sodium Injection market is projected to witness growth at a CAGR of 8.7% during the forecast period, with a market size of USD 205.31 million in 2024.

Asia Pacific Enoxaparin Sodium Injection Market Analysis

According to Cognitive Market Research, the global Enoxaparin Sodium Injection market size was estimated at USD 4415.2 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 1015.50 million in 2024 and will grow at a compound annual growth rate (CAGR) of 13.5% from 2024 to 2031.

• According to Cognitive Market Research, the China Enoxaparin Sodium Injection market size was valued at USD 456.97 million in 2024 and is projected to grow at a CAGR of 13.0% during the forecast period. Enoxaparin Sodium Injection surged in China due to increasing prevalence of thromboembolic conditions and cardiovascular diseases.
• The Japan Enoxaparin Sodium Injection market is projected to witness growth at a CAGR of 12.0% during the forecast period, with a market size of USD 140.14 million in 2024.
• The India Enoxaparin Sodium Injection market had a market share of USD 121.86 million in 2024 and is projected to grow at a CAGR of 15.3% during the forecast period. India's advancements in healthcare infrastructure
• The South Korean Enoxaparin Sodium Injection market is projected to witness growth at a CAGR of 12.6% during the forecast period, with a market size of USD 101.55 million in 2024.
• The Australian Enoxaparin Sodium Injection market is projected to witness growth at a CAGR of 13.2% during the forecast period, with a market size of USD 52.81 million in 2024.
• The South East Asia Enoxaparin Sodium Injection market is projected to witness growth at a CAGR of 14.5% during the forecast period, with a market size of USD 70.07 million in 2024.
• The Rest of Asia Pacific Enoxaparin Sodium Injection market is projected to witness growth at a CAGR of 13.3% during the forecast period, with a market size of USD 72.10 million in 2024.

South America Enoxaparin Sodium Injection Market Analysis

According to Cognitive Market Research, the global Enoxaparin Sodium Injection market size was estimated at USD 4415.2 Million, out of which the Latin America held the market share of around 5% of the global revenue with a market size of USD 220.76 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.9% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Enoxaparin Sodium Injection market size was valued at USD 10.05 million in 2024 and is projected to grow at a CAGR of 9.0% during the forecast period. Enoxaparin Sodium Injections flourished in Brazil due to advancements in healthcare infrastructure.
• Argentina's Enoxaparin Sodium Injection market had a market share of USD 3.94 million in 2024 and is projected to grow at a CAGR of 9.3% during the forecast period. Argentina's rising incidence of cardiovascular diseases and deep vein thrombosis.
• Colombia Enoxaparin Sodium Injection market is projected to witness growth at a CAGR of 8.2% during the forecast period, with a market size of USD 2.09 million in 2024.
• Peru Enoxaparin Sodium Injection market is projected to witness growth at a CAGR of 8.6% during the forecast period, with a market size of USD 1.92 million in 2024.
• Chile Enoxaparin Sodium Injection market is projected to witness growth at a CAGR of 11.2% during the forecast period, with a market size of USD 1.69 million in 2024.
• The Rest of Latin America's Enoxaparin Sodium Injection market is projected to witness growth at a CAGR of 10.0% during the forecast period, with a market size of USD 3.78 million in 2024.

Middle East Enoxaparin Sodium Injection Market Analysis

According to Cognitive Market Research, the global Enoxaparin Sodium Injection market size was estimated at USD 4415.2 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 88.30 million in 2024 and will grow at a compound annual growth rate (CAGR) of 11.2% from 2024 to 2031..

• The GCC Countries Enoxaparin Sodium Injection market is projected to witness growth at a CAGR of 12.2% during the forecast period, with a market size of USD 37.79 million in 2024. Enoxaparin Sodium Injection sales flourish due to the presence of major market players.
• The Egypt Enoxaparin Sodium Injection market is projected to witness growth at a CAGR of 11.5% during the forecast period, with a market size of USD 9.27 million in 2024.
• The South Africa Enoxaparin Sodium Injection market is projected to witness growth at a CAGR of 12.2% during the forecast period, with a market size of USD 13.95 million in 2024. Enoxaparin Sodium Injection sales flourished in South Africa due to rising awareness among healthcare professionals and patients
• The Turkey Enoxaparin Sodium Injection market is projected to witness growth at a CAGR of 10.7% during the forecast period, with a market size of USD 7.59 million in 2024.
• The Nigeria Enoxaparin Sodium Injection market is projected to witness growth at a CAGR of 10.3% during the forecast period, with a market size of USD 9.27 million in 2024.
• The Rest of the MEA Enoxaparin Sodium Injection market is projected to witness growth at a CAGR of 10.2% during the forecast period, with a market size of USD 10.42 million in 2024.

Enoxaparin Sodium Injection Market Analysis

Enoxaparin Sodium Injection Market Type Segment Analysis

According to Cognitive Market Research, The leading product in the market is the 100 mg/1 mL formulation. This dose has been widely used in clinical treatment for many indications, such as the prevention and treatment of thromboembolic disorders. The obvious reason for its popularity undoubtedly lies in its efficacy as well as the advantage of offering a standard dosage that can easily be adapted to both hospital and outpatient facilities.

The fastest-growing segment was 30 mg/0.3 mL formulation. With the fast-paced growth of interest in outpatient care and in treating patients of lower body weight or patients with specific medical conditions requiring dosages less than the normal dosage, this particular segment was growing at a rapid pace. In fact, with growing awareness and movement towards the concept of personalized medicine, demand for this smaller dosage form gained immense importance to become a leader in the market.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Enoxaparin Sodium Injection Industry. Request a Free Sample PDF!

Enoxaparin Sodium Injection Market Application Segment Analysis

According to Cognitive Market Research, Deep Vein Embolism Treatment is the leading product segment. This is because DVT is an extremely common and fatal medical condition if it progresses into a pulmonary embolism, which thus needs proper anticoagulation therapy. Anticoagulation therapy in a patient diagnosed with DVT is most preferably done through enoxaparin treatment, thus holding a majority market share

The Prevents Intravenous Thrombosis segment is growing rapidly. This is because more and more awareness has been created about the risks of hospital-acquired thrombosis, especially in surgical or immobilized patients. As healthcare providers are increasingly considering preventive measures to lower thromboembolic events, the demand for Enoxaparin increases for this segment, portraying a trend toward the proactive management of thrombotic conditions

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Enoxaparin Sodium Injection End use Segment Analysis

• Hospital
• Clinic
• Others

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion